{"label": "fake", "id": "db6d08f6110be4fd155466dc16910b25", "date": "2020-02-02 22:20", "user_id": "ab89a63b10d1caf3f8843db8da66ba22", "text": "白宫官网消息：吉利德公司的瑞德西韦明日（2月3日）开始在中国临床试验。经特朗普总统特批，同意将该药物专利豁免，向中国紧急公开药物分子结构。至2020年4月27日，允许中国仿制此药用于治疗冠状病毒患者。 ​​​ ​​​​", "pic_url": [], "video_url": "", "comment_num": "10", "repost_num": "4", "like_num": "10", "analysis": "经查，此微博称“经特朗普总统特批，同意将该药物专利豁免”不实，据@环球时报 记者发现这事并不存在。详情：https://weibo.com/1974576991/IsuVnAjmV，被举报人言论构成“发布不实信息”。现根据《微博举报投诉操作细则》（<http://service.account.weibo.com/roles/guiding>）第19条，对被举报人处理如下：扣除信用积分2分。上述处理在公布后60分钟内生效。", "comments": [{"id": "8ee5dc591d7d93c3c895a9f335ee7f6c", "date": "2020-02-02 22:59", "user_id": "6d39edd760584f39ec0e5d779880e933", "text": "：自己的流感能治好吗，否则就是来收智商税", "pic_url": ""}, {"id": "e75c19f2bad75dc2e5d0761760aaad7d", "date": "2020-02-02 22:32", "user_id": "f7e16d0c176746e4e774e56fff812beb", "text": "：请问瑞德西韦专利豁免的官方报道来源在哪？", "pic_url": ""}, {"id": "917ccecbbbe66d616bb5b5a5ea892ef0", "date": "2020-02-02 22:24", "user_id": "e37d4c43b1501e866446f52208bfed5f", "text": "：哪里来的消息？不可信", "pic_url": ""}, {"id": "b72f82a00a2295c1b8f1a6deb05cdee0", "date": "2020-02-02 22:48", "user_id": "75b59fe989c6273bbec18fced2f6f4fc", "text": "：要钱还是要命，特没谱拎得清", "pic_url": ""}, {"id": "a915630febac590b3a623d9582e9072f", "date": "2020-02-03 13:19", "user_id": "c350bc0f1633b17bd3fe194588d37a9e", "text": "：已经确定是谣言", "pic_url": ""}], "reposts": [{"id": "8508478647545f64dd4e07222775c6bd", "date": "2020-02-03 02:56", "user_id": "e9e3252e3697968b1da44532ab9b5640", "text": "快转微博", "pic_url": []}, {"id": "4fd88e0fc73c9ecfa0ffa1556ae7f7d9", "date": "2020-02-03 02:46", "user_id": "0dca584d51e9a48a9e90e0410984f529", "text": "快转微博", "pic_url": []}, {"id": "dd36a2d869208e1148c1ac41d72a7c6d", "date": "2020-02-02 22:44", "user_id": "ddda63d04ee68147921549bc4ef2316b", "text": "转发微博", "pic_url": []}]}